English | 简体中文 | 繁體中文 | 한국어
 All Press Releases

The Gourmet's Guide: Using Your TravelKon eSIM to Hunt for Japan's Best Ramen, Sushi, and Street Food
Dec 04, 2025 17:45 HKT
Eisai Presents New Data on the Continued and Expanding Benefit of LEQEMBI(R) (lecanemab-irmb) Maintenance Treatment in Early Alzheimer's Disease at CTAD 2025
Dec 04, 2025 17:36 HKT
Spritzer Celebrates Global and Regional Brand Excellence 2025
Dec 04, 2025 12:45 HKT
Honda、新型「CR-V」の先行予約開始
Dec 04, 2025 11:30 HKT
在聯泓格潤「超級工廠」看見綠色材料全鏈路
Dec 04, 2025 09:36 HKT
在联泓格润"超级工厂" 看见绿色材料全链路
Dec 04, 2025 09:14 HKT
阿曼十年黃金居留計劃吸引全球投資者尋求穩定與長期通達
Dec 04, 2025 08:00 HKT
阿曼十年黄金居留计划吸引全球投资者寻求稳定与长期准入
Dec 04, 2025 08:00 HKT
Oman's 10-Year Golden Residency Program Attracts Global Investors Seeking Stability and Long-Term Access
Dec 04, 2025 07:00 HKT
OMP的AI驅動Unison Planning(TM)平台提升麥考密克公司供應鏈敏捷性
Dec 03, 2025 22:00 HKT
OMP人工智能驱动的Unison Planning(TM)平台助力麦考密克提升供应链敏捷性
Dec 03, 2025 22:00 HKT
OMP's AI-driven Unison Planning(TM) Platform Enhances Supply Chain Agility for McCormick & Co.
Dec 03, 2025 22:00 HKT
The 26th Hong Kong Forum marks successful completion
Dec 03, 2025 21:44 HKT
DesignInspire opens today, showcasing over 260 local and global design brands
Dec 03, 2025 20:52 HKT
K-POP界の重鎮、MOVAブロックチェーンの将来性を確信... 2万人超の業界エリートがエコシステム共同構築に参画
Dec 03, 2025 20:30 HKT
Focus Graphite Appoints Renowned Battery Executive Dr. Sunho Kang as Strategic Advisor for Cell Technology
Dec 03, 2025 18:09 HKT
New Data Presented at CTAD 2025 Confirms Pharmacological Effect of LEQEMBI(R) (lecanemab-irmb) on Neurotoxic Aβ Protofibrils in CSF
Dec 03, 2025 17:19 HKT
Mitsubishi Motors Launches the All-New Destinator in Vietnam
Dec 03, 2025 17:00 HKT
科技與豪華共振 賽力斯定義中國高端新能源汽車新範式
Dec 03, 2025 15:45 HKT
科技与豪华共振 赛力斯定义中国高端新能源汽车新范式
Dec 03, 2025 15:37 HKT
<< Previous Next >>
 Releases By Language
All
English
Indonesian
Japanese
Korean
Thai
Trad. Chinese
Simp. Chinese
Vietnamese
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: